Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
215 Leser
Artikel bewerten:
(0)

PENTAX Medical launches MILES FOR HEALTH campaign to celebrate the 100-year anniversary of its origin

The global MILES FOR HEALTH campaign aims to raise awareness of the importance of cancer research, with PENTAX Medical set to donate up to US$125,000 for World Cancer Research Fund

TOKYO, May 29, 2019 /PRNewswire/ -- PENTAX Medical, a leading provider of endo-imaging solutions, will soon celebrate the 100th anniversary of the foundation of Asahi Optical Joint Stock Co., the original manufacturer of PENTAX-branded products. To commemorate this achievement, PENTAX Medical will donate up to US$25,000 in addition to the US$100,000 already pledged to the World Cancer Research Fund. This gesture echoes the company's ongoing commitment to help improve the awareness, detection, diagnosis and treatment of cancer, which is a value at the core of PENTAX Medical's history.

Through its MILES FOR HEALTH campaign, PENTAX Medical will donate an additional UIS$1 to charity* for every mile covered by anyone who registers. For more info, please visit the MILES FOR HEALTHTM website - www.milesforhealth.com

On May 29, 2019, the company will also launch its "MILES FOR HEALTH - 100 Years of PENTAX campaign" to help raise awareness of the importance of cancer research. Anyone, including staff, partners and customers, across the globe will be able to register to take part. Whether it's one mile or a marathon, everyone will be able to do their bit to help raise money for the World Cancer Research Fund. These miles can be achieved by any method of self-propulsion such as running or walking, and any distance will count - small or large.

Gerald W. Bottero, Global President, PENTAX Medical, said, "It is an honor to preside over this landmark moment in our Company's great history. I am delighted that we are able to celebrate this remarkable achievement with a charitable gesture, one that we hope reflects our ongoing commitment to the improved awareness, detection, diagnosis and treatment of cancer."

Dr Giota Mitrou, Director of Research at World Cancer Research Fund, said: "We are extremely grateful to PENTAX Medical for their incredibly generous donation. This sum of money will help fund vital research into cancer prevention and survival as well as enable us to continue empowering people to lower their risk of cancer. We want to live in a world where no one develops a preventable cancer and this money will go towards our efforts."

With a rich history of innovation, initially manufacturing spectacle lenses and later camera lenses, PENTAX first entered the endoscopy market in 1977 with the FB-17A - it's first Broncho Fiberscope. Since then, endoscopy has become a vital tool in the detection, diagnosis and treatment of many cancers. Now a division of HOYA Group, PENTAX Medical continues to innovate, developing leading-edge optical technologies, including cutting-edge solutions that support each step of the clinical pathway. From screening to diagnosis and into therapy, PENTAX Medical offers clinicians various advanced solutions to enhance productivity and improve patient outcome.

Working towards the next 100 years and beyond, PENTAX Medical's mission is to continue aiding the global medical community, providing quality, innovative and easy-to-use endoscopic products and services. Together with its customers and partners around the world, PENTAX Medical is committed to help improve the detection, diagnosis and treatment of cancer.

To sign up and contribute yourMILES FOR HEALTHtoday, visit www.milesforhealth.com.

*up to a total of US$25,000

About PENTAX Medical

PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe.

For more information, please visit: www.pentaxmedical.com.

About World Cancer Research Fund

World Cancer Research Fund is one of the world's leading cancer prevention charities, and is dedicated to funding life-changing research into the prevention of cancer through diet and lifestyle. We cut through the jargon to turn the latest global research on cancer prevention and survival into practical, straightforward advice and information, helping anyone who wants to reduce their risk of developing cancer to make fully informed lifestyle choices.

Find out more: www.wcrf-uk.org

Photo - https://mma.prnewswire.com/media/887494/PENTAX_MILES_FOR_HEALTH.jpg

© 2019 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.